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ABSTRACT  
Background: Since the introduction of pharmaceutical care in the 1990’s, a lot of progress has been made, but misconceptions and barriers  to 
its full implementation still exist. Around the world, community pharmacists are moving from supplying and dispensing medications to gradual 
introduction of pharmaceutical care into their practice.  
Objectives: This study evaluated the attitude and practice of pharmaceutical care among community pharmacists in Delta State, Nigeria.  
Methods: These were achieved through the use of a 30 item questionnaire pretested and administered to 50 community pharmacists that 
gathered for their quarterly meeting in Asaba, Delta State. Questions were in four parts, first part assessed demographics of respondents, 
second part was on attitude to pharmaceutical care, third part focused on practice and the fourth part was on barriers to practice and how to 
overcome them. Data were analyzed through chi square statistics using SPSS 23.  A P-value of less than 0.05 was considered statistically 
significant. 
Results: Out of 50 questionnaires distributed, 32 were returned, giving a response rate of 64%.  Majority of the respondents (28.1%) were aged 
50-59 years, more than half (62.5%) were males. The mean age was 40.5 years ± 13.7 years. Majority of the respondents (71.9%) were married, 
more than half (56.3%) had Bachelor of Pharmacy as sole degree. Half (50.0%) were residing in Warri while more than a third (40.6%) had 
been in practice for 1-5 years. Attitude was positive (51.2%), practice was poor (39.0%).  Reasons for not practicing pharmaceutical care 
ranged from lack of personnel (21.9%), lack of collaboration with other healthcare providers; lack of space and non-acceptance by physicians 
and nurses were 18.8% each, lack of pharmaceutical care skills (9.4%) and pharmaceutical care is time consuming (6.5%). Analysis of 
educational status versus number of respondents involved in identification of errors was significant at 2 = 21.013, P = 0.002 with Bachelor of 
Pharmacy respondents (56.3%) identifying most errors. 
Conclusion: Attitude of community pharmacists to pharmaceutical care from this study was positive while practice was poor. Interventions 
such as update lectures to improve awareness of Pharmaceutical care and further attitudinal change are recommended.  
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INTRODUCTION 
Much progress has been achieved since the introduction of 
pharmaceutical care in 1990; an innovative approach to 
contemporary pharmacy practice. Pharmaceutical care is the 
responsible provision of drug therapy for the purpose of 
achieving definite outcomes which improve a patient’s 
quality of life.1,2,3,4,5  These outcomes include cure of  disease, 
elimination or reduction of patient's symptoms, arresting or 
slowing of a disease process or preventing a disease.  In 
Pharmaceutical care, the pharmacist cooperates with the 
patient and other professionals in designing, implementing, 
and monitoring a therapeutic plan that will produce specific 
therapeutic outcomes for the patient.2 Pharmaceutical care 
practices all over the world are quite diverse because of the 
different languages and legal, political and healthcare 
systems in the nations involved.4 In China, the 
implementation of pharmaceutical care in Chinese hospital 
pharmacies continues to spread, whereas it has not been a 
priority of community pharmacy. In Nigeria, pharmaceutical 
care is still at developmental stage.6  
A community pharmacy is a health care facility that 
specializes in providing pharmaceutical services to the 
Amibor et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(6-s):164-171 
ISSN: 2250-1177                                                                                  [165]                                                                                 CODEN (USA): JDDTAO 
community or people at the grass root. They serve the 
society in the area of provision of drug products and various 
pharmaceutical services related needs. They are a unique 
hybrid of professionalism, business and health care. 
Community pharmacists dispense pharmaceuticals; provide 
counseling services on over the counter drugs and 
prescriptions, and advice on use of medical equipment and 
home care supplies. They are also involved in health 
education of patients on dietary habits, lifestyle changes, 
personal and environmental hygiene. Community 
pharmacies include corporately owned chain pharmacy 
shops, pharmacy departments in supermarkets or 
independently owned pharmaceutical shops that provide 
prescription services plus lines of health related products.7    
Community pharmacies service out of stock prescriptions 
from government hospitals. Community pharmacists are the 
most easily accessible healthcare professionals to the public.8  
Not all community pharmacy premises in Nigeria carry out 
pharmaceutical care functions. A few chain pharmacies carry 
out medication profiling, a complete and comprehensive 
summary of consumers current medications. There are still 
barriers that hinder the provision of pharmaceutical care 
that have to be overcome. For example, supermarkets and 
pharmacy chains, seem to put little emphasis on care 
provision.4 Lack of involvement of pharmacists is one of the 
barriers to effective implementation of pharmaceutical care 
services in community pharmacies in Nigeria.7  Others are 
limited consulting time, lack of private counseling area at the 
community pharmacies, perception that patients are not 
willing to pay for specialized care, unfriendly inter-
professional dispositions and lack of enforcement of 
standards for pharmacists in their daily practice. 7, 9,10,11,12  In 
Nigeria, some community pharmacists do not have 
pharmacists covering the premises throughout the period 
the premises are open, because of inadequate manpower. 
Moreover, in community pharmacy setting, the pharmacist 
has limited or no interactions with other healthcare workers 
in Nigeria. These factors have not only compromised the 
early implementation of pharmaceutical care in community 
pharmacies in Nigeria, but have had negative impact on 
clinical pharmacy practice in the health care delivery system 
in Nigeria.  
Various studies have been conducted on the attitude, and 
practice of pharmaceutical care in Nigeria and elsewhere in 
the world. A study carried out in Asaba among pharmacists 
revealed poor knowledge, weak attitude and poor practice.13 
Another study carried out to in New Zealand found out that 
over 60% of pharmacists surveyed had a correct 
understanding of pharmaceutical care and that the future of 
pharmacy would depend on the provision of services other 
than dispensing.14 Barriers to implementation identified 
were insufficient time, absence of reimbursement system, 
lack of therapeutic knowledge, clinical problem solving skills, 
finance, appropriate space, patient demand, access to patient 
medical records, and data on the value of pharmaceutical 
care.14 A  study carried out in China15 showed that 
respondents spent most of their work time performing 
prescription checks and providing patients with directions 
for drug administration, dosage, and precautions, but they 
tended to ignore health promotion within and outside of 
pharmacy settings. Factors inﬂuencing the implementation 
of pharmaceutical care were: lack of external conditions for 
developing or providing pharmaceutical care, lack of time 
and skills, absence of information and economic incentive, 
and lack of full support from other health professionals.15 
A study carried out in 200316 showed that the attitudes of 
Nigerian pharmacists towards Pharmaceutical care were 
favorably high irrespective of practice settings. Earlier in 
2002, some elements of pharmaceutical care activities such 
as medication history taking, blood pressure measurement 
among others was reported to have been practiced by some 
community pharmacists in Benin City.17 Low satisfaction of 
patients with pharmaceutical services without 
pharmaceutical care has been reported as well. A study in 
Kaduna reported a deficit in practice of pharmaceutical care, 
a positive attitude towards pharmaceutical care and lack of 
competence to practice pharmaceutical care.18 Community 
pharmacy practice is largely underdeveloped in Nigeria.7 
Limited studies explored the role of pharmaceutical care in 
community pharmacies in Nigeria.13, 18,19,20 Studies 
conducted in other countries provide insight on these 
issues.21, 22,23,24,25,26, 27, 28, 29, 30, 31,32  Another study suggested 
that pharmaceutical care services provided to hypertensive 
patients showed improved blood pressure control and 
overall patients satisfaction with pharmaceutical care 
services.33  This underscores the potentials of community 
pharmacies at improving health care services. Another study 
carried out in Ogun State concluded that attitude of 
pharmacists towards implementation of pharmaceutical care 
was good but the ability to implement it was weak.20 A study 
carried out to determine the extent of counseling services in 
community pharmacies, revealed that 25% of pharmacists 
never talked with their patients while 47% of all patients 
never received any oral drug information from pharmacy 
staff.7 
The objectives of this study were to determine the attitude 
and practice of pharmaceutical care among community 
pharmacists in Delta State and to identify barriers to the 
implementation of pharmaceutical care. 
METHODS 
The study was carried out among community pharmacists 
practicing in Delta State, mid-Western Nigeria, as they 
gathered for the quarterly meeting of their association in the 
state capital in 2017. Delta State is one of the 36 states in 
Nigeria, and was created in 1991. The state has a population 
of 4,112,445, comprising 2,069,309 males and 2, 043,136 
females 34,35,36  and was created on 27th August, 1991, with 
Asaba as the capital. She is one of the oil producing states of 
the country and also an agricultural state.  Other mineral 
deposits in the state include lime, kaolin, laterite and clay. 
The state is situated in the South South Geo-Political Zone of 
Nigeria, with Warri as the biggest commercial city and Asaba 
as the state capital. Asaba is strategically located on a hill, at 
the Western edge of the majestic River Niger. The Historic 
River Niger is a trans- West African link beginning from the 
Futa Jalon highlands in Guinea and empties into the Atlantic 
Ocean in the Niger Delta region of Nigeria.37  The greater 
Asaba occupies a land mass of over 300 square kilometers. 
Since becoming the Delta State capital, Asaba has grown in 
population from the last census figure of 149,60338 in 2006. 
The people are very hospitable, and Asaba now maintains a 
cosmopolitan population of predominantly non-indigenous 
people.37   The state has 25 local government areas, about 58 
secondary healthcare institutions, over 100 primary health 
care centres and a teaching hospital owned by the state 
government at Oghara, in Ethiope Local Government area of 
the state. and a Federal Medical Centre based in Asaba, a 
tertiary institution owned by the federal government. There 
are over 150 community pharmacies in the state, with 
majority practicing in Warri, the most densely populated 
town in the state, reputed to have over 80 community 
pharmacies and with a population of 311,970 38  from 
national population figures of 2006, while Asaba has about 
30 registered pharmacies. The remaining 40 community 
pharmacies are spread over the remaining towns in the state 
such as Sapele, Ughelli, Agbor and Abraka. The registered 
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pharmacists in the state have an association known as the 
Association of Community Pharmacists of Nigeria (ACPN) 
Delta State Branch, divided into 2 zones, Warri zone and 
Asaba zone, because of the large land mass of the state and 
for ease of access of members; members are registered into 
each zone based on proximity. The Association rotates 
meetings between the zones from time to time. It was at one 
of such meetings in Asaba Zone that the interviews were 
conducted. 
Study population 
The study population comprised 50 community pharmacists 
that came from all over Delta State to attend a scheduled 
meeting of the Delta State Branch of the Association of 
Community Pharmacists of Nigeria at Asaba, the state capital. 
Sampling method 
Well structured, self-administered questionnaires were 
randomly distributed to 50 community pharmacists that 
gathered for their general meeting.  Consent to undertake the 
study was sought and obtained from the leadership of the 
Association of Community Pharmacists of Nigeria, Delta State 
Branch. Also, informed consent was sought and obtained 
from respondents before they received the questionnaires. A 
pretest was carried out randomly among 10 pharmacists in 
Asaba, after which minor errors in typing were corrected, 
before the corrected questionnaires were administered to 
the general respondents.. 
Data collection and analysis 
A total number of 50 questionnaires were self-administered 
to pharmacists. The questionnaire was made anonymous, 
and structured into four parts. The first part assessed 
demographics of respondents, second part was on attitude to 
pharmaceutical care, third part focused on practice and the 
fourth part was on barriers to practice and how to overcome 
them. The questionnaires contained open and closed 
questions. The essence of the open questions was for the 
respondents to volunteer additional information in the 
desired areas. The questionnaires were collated, and data fed 
into the computer and analyzed using Statistical Package for 
Social Sciences (SPSS Version 23). Results were presented as 
frequency and percentage of variables. Chi Square statistics 
was used to test for level of significance of attitude and 
practice. P-value of less than 0.05 was considered to be 
statistically significant. 
Scoring scale 
Scoring scale for attitude of respondents to pharmaceutical 
care was: 0-50% (Negative), 51-100% (Positive) while that 
of practice of pharmaceutical care was: 0-50%, (Poor), 51-
70% average, 71-100% (Good).  
RESULTS 
A total of 50 questionnaires were distributed, only 32 were 
returned, giving a response rate of 72%. Majority of the 
respondents (28.1%) were aged 50-59 years, more than half 
(62.5%) were males. The mean of the age was 40.5 years ± 
13.7 years. Majority of the respondents were married 
(71.9%), more than half (56.3%) had Bachelor of Pharmacy 
as sole degree. Exactly half (50.0%) of the respondents were 
residing in Warri, nearly half (40.6%) had been in practice 
for 1-5 years. Other demographic information about the 
respondents are contained in Table 1.  Few (21.9%) had 
attended more than six workshops on pharmaceutical care, 
about half (56.3%) spent 2-3 days maximum outside their 
location to attend workshops on pharmaceutical care. About 
half (53.1%) reported that they always applied 
pharmaceutical care in their practice. Few (28.1%) 
sponsored themselves to workshops on pharmaceutical care. 
Majority (65.6%) agreed that they will sponsor themselves 
to workshops on pharmaceutical care. Majority (56.3%) 
spent maximum of 2-3 days to attend lectures on 
pharmaceutical care outside their location of practice. Nearly 
all (93.8%) agreed they identified errors in patient 
prescriptions. Types of errors identified ranged from drug 
interactions and inappropriate prescriptions (9.4%) each, 
duplicate therapy (6.3%), dosage too high and dosage too 
low (3.1%) each, combination of types of error (53.1%) and 
all categories of errors (6.3%). Methods used in monitoring 
patients included direct patient interview (50.0%), blood 
pressure monitoring (12.5%), documented test results from 
laboratories (6.3%). 
Reasons for not practicing pharmaceutical care ranged from 
lack of personnel (21.9%), lack of collaboration with other 
healthcare providers (18.8%), lack of space (18.8%), non 
acceptance by physicians and nurses (18.8%), lack of 
pharmaceutical care skills (9.4%) and pharmaceutical care is 
time consuming (6.5%).  Suggestions on how to improve 
pharmaceutical care practice in the state included all 
pharmacists to acquire additional training in the Doctor of 
Pharmacy degree programme (12.5%), pharmaceutical care 
should be taught in all schools of pharmacy (6.3%), 
maintenance of privacy for patient counseling (9.4%), 
improved professional relationship with patients (3.1%), 
improved relationship with other healthcare providers 
(3.1%), improved communication skills (6.3%),  and 
financial remuneration for pharmaceutical care activities 
carried out (3.1%), and all of the above (50.0%).  
Analysis of sex of respondents versus number that 
monitored patients improvement was statistically significant 
at 2 = 9.931, P = 0.042, with males (62.5%) monitoring more 
than females (15.6%). Analysis of marital status versus 
respondents that monitored improvement in patients 
condition was statistically significant at 2 =16.072, P = 0.013 
with married respondents (65.6%) monitoring better than 
singles (21.9%) and widows (3.1%). Analysis of marital 
status versus number of respondents that updated their 
knowledge regularly was statistically significant at 2 = 
32.768, P = 0.000 with married respondents updating most 
(65.6%), followed by singles (21.9%). Analysis of marital 
status versus methods used in monitoring showed 
significance at 2 = 24.62, P = 0.003 with married 
respondents using more of direct patient interviews (50.0%), 
blood monitoring (12.5%) than singles.  Analysis of 
educational status versus number of respondents involved in 
identification of errors was significant at 2 = 21.013, P = 
0.002 with Bachelor of Pharmacy respondents (56.3%) 
identifying more errors, followed by FPCPharm (21.9%), 
Pharm. D. (12.5%) and Masters (6.3%). Analysis of town of 
practice versus types of errors identified was significant at 2 
= 41.621, P = 0.047, with Warri identifying most (50.0%), 
followed by Asaba (37.5%), Ughelli (6.3%) and Agbor (3.1%) 
Analysis of educational status versus identification of errors 
was statistically significant at 2  = 21.013, P = 0.002, with 
respondents with bachelor of pharmacy identifying most 
(56.3%), followed by fellows (21.9%), doctor of pharmacy 
(15.6%) and masters (6.3%). Analysis of age of respondents 
versus number documenting their pharmaceutical care 
activities was statistically significant at 2 = 18.469, P = 
0.048, with 50-59 years documenting most (28.1%) followed 
by 40-49 (25.0%), 30-39 (21.9%) 20-29% (18.2%) was least 
with more than 60 years. 
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Table 1:  Demographics of Respondents 
Variables                    Values                            Frequency                 Percentage  % 
Sex 
                                        Male                                    20                                  62.5 
                                        Female                                 8                                   25.0 
                                        No response                       4                                   12.5    
Age  Group                                                            
                                        20-29                                    6                                   18.8 
                                        30-39                                    7                                   21.9   
                                        40-49                                    8                                   25.0 
                                        50-59                                    9                                   28.1 
                                        60 and above                      1                                   3.1 
                                        No response                        1                                   3.1 
Marital status 
                                          Single                                    7                                   21.8 
                                          Married                                23                                 71.9 
                                          Widowed                             1                                    3.1 
                                          No response                        1                                    3.1 
 Educational status                          
                                            B. Pharm                           18                                    56.3  
                                            Pharm. D.                           5                                     15.6 
                                            Masters                              2                                      6.3                                             
                                            FPCPharm                         7                                      21.9 
Length of practice                        
                                            < 1                                       1                                    3.1 
                                            1-5                   13                                  40.6 
           6-10                                     3                                    9.4 
                                            11-15                                   3                                    9.4 
                                            >15                                      12                                  37.5 
   Town of practice 
                                             Asaba                                 12                                   37.5 
                                             Warri                                  16                                  50.0 
                                             Agbor                                 1                                     3.1 
                                             Ughelli                               2                                     6.3 
                                             Other                                  1                                     3.1          
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Table 2: Attitude of Respondents to pharmaceutical care 
Perception                                                                                                     Agree             Neutral           Disagree                                           
                                                                                                
Do you think PC is a timely innovation to Pharmacy practice            15(46.9)          0(0)                 17(53.1) 
                                                            
Do you think PC is not necessary in our practice           0 (0)              21(65.6)            11(34.4) 
 
Do you think PC will lead to better patient outcomes        23(71.9)         9(28.1)               0 (0) 
 
Do you think PC is very demanding in terms of time         0 (0)              21(65.6)             11(34.4) 
 
Willingness to sponsor yourself to workshops                   21 (65.6)       7(21.9)               4 (12.5) 
on PC outside location of practice 
 
Do you sponsor yourself to training workshops on PC        9(28.1)         18(56.3)             5 (15.6) 
 
Do you think the knowledge you acquired from PC workshop            21(51.6)        9(28.1)             2(6.3) 
improved your professional relationship with your patients 
                                                 
Do you apply PC to all your patients                             17(53.1)        1(3.1)               14(43.8) 
 
Total                                                                                      51.2%           33.4%             15.4%  
PC--------Pharmaceutical care 
 
Table 3: Practice of Pharmaceutical Care by Respondents 
Attribute                                                                                                  Yes                        No                                                                                                                                          
 
Monitoring improvement in patient response                       29(90.6)               3(9.4) 
 
Methods used in monitoring: 
Direct patient interview                                                                 16(50.0)             16(50.0)       
Blood pressure monitoring                                                              4(12.5)                28(87.5)              
Reported tests carried out on patients                                            2(6.3)                 30(93.8)                                                                                                            
 
Identification of errors in patient prescriptions                   30(93.8)              2(6.3)           
 
Counsel patients (with drug therapy problems)                   12(37.5)              20(62.5)                                                          
 
Medication therapy management                                                5(15.6)                27(84.4)              
 
Carry out medication review with patients                             3(9.4)                  29(90.6) 
 
Carry out medication review with physicians                        9(28.1)               23(71.9) 
 
Documentation of pharmaceutical care activities                14(43.8)             18(56.3) 
 
Total                                                                                                39.0%                61.0%                                                             
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Table 4: Types of Errors identified 
Error                                                              Frequency                     Percent 
Dosage too high                                            1                          3.1 
Dosage too low                                             1                          3.1 
Inappropriate compliance                         3                         9.4 
Duplicate therapy                                         2                         6.3   
  More than 1 error                                         17                       53.1 
  All                                                                       2                         6.3 
  No response                                                    3                         9.4 
 Total                                                                  32                     100.0 
 
Table 5:  Factors associated with monitoring patients’ improvement among respondents. 
                                                                             (%) Respondents 
Variable               2                      ٭P           that monitor patients improvement                          Inference               
Sex                     9.931        0.042                                                                                            Statistically significant  
    Males                                                                 62.5 
    Females                                                            16.6 
 
Marital status      16.072       0.013                                                                                        Statistically significant    
      Married                                                              65.6 
      Singles                                                                21.9 
      Divorced 
      Widowed                                                           3.1 
 
Table 6: Reasons for not practicing Pharmaceutical care by Respondents 
Attribute                                                                                        Yes                     No                    No 
                                                                                                                                       Response 
Fear of change                                                                                   0                     3(9.4)             29(90.6) 
Lack of pharmaceutical care skills                                              3(9.4)           3(9.4)              26(81.3) 
Lack of collaboration with other healthcare providers       6(18.8)         3(9.4)              23(23) 
Lack of space                                                                                     6(18.8)         2(6.3)              24(75.0) 
Non acceptance by physicians and nurses                               6(18.8)         2(6.3)              24(75.0)  
Pharmaceutical care is time consuming                                   2(6.3)           3(9.4)               26(81.3) 
Lack of personnel                                                                            7(21.9)         2(6.3)               23(71.9) 
 
Table 7: Number of workshops attended on Pharmaceutical care 
Number of workshops attended                Frequency                        Percentage (%)                                                                                               
     None                                                                        9                                                28.1 
   
    1                                                                                2                                                 6.3    
 
   2-5                                                                            13                                               40.6   
 
   6 and above                                                            7                                                 21.9 
 
   No response                                                           1                                                 3.1 
 
 
Amibor et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(6-s):164-171 
ISSN: 2250-1177                                                                                  [170]                                                                                 CODEN (USA): JDDTAO 
DISCUSSION 
The results of this study are quite interesting and agree with 
studies from other parts of the world. 7,13,18,20,39 There were 
more males than females in this study, which is similar to 
results of other studies.13,39  Majority of respondents were 
aged 50-59 years, while most had been in practice for 1-5 
years. This result differs slightly from a similar study in 
Asaba13 which had majority aged 31-40 years and length of 
practice of 1 -10 years.   Half of the respondents were 
practicing in Warri, the commercial capital of the state. 
In this study, attitude of respondents to pharmaceutical care 
was positive (51.2%). The result is in line with those of 
several studies.6, 18,20  For instance the Survey of Attitude, 
Perception and Practice of Pharmacists in Ogun State, South-
Western Nigeria20 on Pharmaceutical Care Implementation 
revealed that attitude of pharmacists towards 
implementation of Pharmaceutical care was good. The result 
also agrees with the study carried out in Benin City which 
concluded that the attitudes of Nigerian pharmacists 
towards Pharmaceutical care were favorably high 
irrespective of the practice settings. It also agrees with the 
Kaduna Study18 which recorded a positive attitude to 
Pharmaceutical care. This is also in agreement with the 
study6 among University of Nigeria Pharmacy students 
which revealed positive attitude among them.    
Practice of pharmaceutical care recorded in this study was 
poor (39.0%). This result is similar to that of an earlier study 
conducted in Asaba13 which recorded a poor practice of 
50.8%. It is also similar to the Kaduna study18 which 
recorded a deficit in practice of pharmaceutical care. It is 
interesting to note that in this study nearly all respondents 
(93.8%) were involved in identification of errors in patient 
prescriptions. Overall however, practice was poor. 
One reason for the poor practice of pharmaceutical care 
recorded in this study may have been the fact that more than 
half of respondents in this study (56.3%) were sole holders 
of the Bachelor of Pharmacy degree, and they may not have 
acquired the necessary skills to practice pharmaceutical care 
which is taught extensively at the post graduate school and 
doctor of pharmacy degree programmes, while few (21.9%) 
were fellows of the West African Post Graduate College of 
Pharmacists  and very few (15.6%) were holders of the 
Doctor of Pharmacy Degree. This study also revealed that 
more males were involved in monitoring of patient 
improvement than females, with married respondents 
monitoring more than singles. Also, most respondents with 
Bachelor of Pharmacy degree identified the highest number 
of drug therapy problems, probably because they were much 
higher in number (56.3%) than others. They also updated 
their knowledge more, which is to be expected. Most 
respondents practicing in Warri, the commercial capital of 
the state identified the most types of prescription errors 
than those practicing in rural settings and this could be 
explained by the fact that Warri has huge population38 and 
several hospitals, and there is a possibility that the 
respondents there had higher access to patients with 
prescriptions from hospitals than those in rural settings. In 
this study, patients in the age bracket 50-59 years showed 
the highest level of documentation of pharmaceutical care 
activities compared to other age groups. Also, more married 
respondents updated their knowledge than singles (P = 
0.000) 
Reasons for not practicing pharmaceutical care ranged from 
lack of personnel (21.9%), lack of collaboration with other 
healthcare providers (18.8%), lack of space (18.8%), non 
acceptance by physicians and nurses (18.8%), lack of 
pharmaceutical care skills (9.4%) and pharmaceutical care is 
time consuming. (6.5%). These barriers recorded in this 
study are similar to reasons adduced for non practice of 
pharmaceutical care from other studies carried out 
elsewhere in the world.13,18,20  For instance a study7  found 
out that lack of involvement of pharmacists is one of the 
barriers to effective implementation of pharmaceutical care 
services in community pharmacies in Nigeria. Other studies 
concluded that limited consulting time, lack of private 
counseling area at the community pharmacies, perception 
that patients are not willing to pay for specialized care, and 
unfriendly inter-professional dispositions, have limited the 
growth of pharmaceutical care practice in Nigeria especially 
at the community pharmacy level which are all in agreement 
with this study. 6,10,11,12,13  
CONCLUSION 
This study revealed positive attitude but poor practice of 
pharmaceutical care among community pharmacists in Delta 
State as at the time of Study (2017). Barriers to practice of 
pharmaceutical care ranged from lack of personnel, lack of 
collaboration with other healthcare providers, lack of space, 
non acceptance by physicians and nurses and lack of 
pharmaceutical care skills. 
Educational interventions such as more pharmacists going 
back to acquire additional training via the Doctor of 
Pharmacy degree would go a long way to improve the 
practice of pharmaceutical care in the state. Also, all schools 
of pharmacy in the country should be encouraged to 
implement the doctor of pharmacy curriculum in line with 
the approval by the National Universities Commission. 
Community pharmacists in the state should be encouraged 
to create confidential rooms for maintenance of privacy for 
patient counseling. They should also endeavour to improve 
professional relationship with their patients, other 
healthcare providers and improve their communication 
skills as well.  
Limitations of Study 
This study was carried out with the use of questionnaires 
only. It was not possible to directly observe the level of 
implementation of pharmaceutical care by the respondents 
since they were not interviewed in their places of practice.  
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